Wipawan Thangnipon

Wipawan Thangnipon

Auto-generated profile, based on publicly available information

Wipawan Thangnipon

Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Salaya, Nakhonpathom, Thailand

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
WTWipawan Thangnipon
Wipawan Thangnipon
NPNicha Puangmalai
Nicha Puangmalai
RSRungtip Soi-Ampornkul
Rungtip Soi-Ampornkul
NSNirut Suwanna
Nirut Suwanna
PTPatoomratana Tuchinda
Patoomratana Tuchinda
SNSaksit Nobsathian
Saksit Nobsathian
Alzheimer's disease, a progressive neurodegenerative disease, affects learning and memory resulting from cholinergic dysfunction. Scopolamine has been employed to induce Alzheimer's disease-like pathology in vivo and in vitro through alteration of cholinergic system. N-benzylcinnamide (PT-3), purified from Piper submultinerve, has been shown to exhibit neuroprotective properties against amyloid-β-induced neuronal toxicity in rat cortical primary cell culture and to improve spatial learning and memory of aged rats through alleviating oxidative stress. We proposed a hypothesis that PT3 has a neuroprotective effect against scopolamine-induced cholinergic dysfunction. PT-3 (125–200 nM) pretreatment was performed in human neuroblastoma SH-SY5Y cell line following scopolamine induction. PT-3 (125–200 nM) inhibited scopolamine (2 mM)-induced generation of reactive oxygen species, cellular apoptosis, upregulation of acetylcholinesterase activity, downregulation of choline acetyltransferase level, and activation of p38 and JNK signalling pathways. These findings revealed the underlying mechanisms of scopolamine-induced Alzheimer's disease-like cellular dysfunctions, which provide evidence for developing drugs for the treatment of this debilitating disease.

1 August 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
NSNirut Suwanna
Nirut Suwanna
WTWipawan Thangnipon
Wipawan Thangnipon
RSRungtip Soi-Ampornkul
Rungtip Soi-Ampornkul

1 November 2013 in Neuroscience Letters
Verified
Journal Article
Closed access
WTWipawan Thangnipon
Wipawan Thangnipon
NPNicha Puangmalai
Nicha Puangmalai
VCVorapin Chinchalongporn
Vorapin Chinchalongporn
CJChanati Jantrachotechatchawan
Chanati Jantrachotechatchawan
NKNarisorn Kitiyanant
Narisorn Kitiyanant
SNSaksit Nobsathian
Saksit Nobsathian

4 June 2015 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
VCVorapin Chinchalongporn
Vorapin Chinchalongporn
PKPeter Koppensteiner
Peter Koppensteiner
DPDeborah Prè
Deborah Prè
WTWipawan Thangnipon
Wipawan Thangnipon
LBLeonilda Bilo
Leonilda Bilo
OAOttavio Arancio
Ottavio Arancio
In order to understand and find therapeutic strategies for neurological disorders, disease models that recapitulate the connectivity and circuitry of patients’ brain are needed. Owing to many limitations of animal disease models, in vitro neuronal models using patient-derived stem cells are currently being developed. However, prior to employing neurons as a model in a dish, they need to be evaluated for their electrophysiological properties, including both passive and active membrane properties, dynamics of neurotransmitter release, and capacity to undergo synaptic plasticity. In this review, we survey recent attempts to study these issues in human induced pluripotent stem cell-derived neurons. Although progress has been made, there are still many hurdles to overcome before human induced pluripotent stem cell-derived neurons can fully recapitulate all of the above physiological properties of adult mature neurons. Moreover, proper integration of neurons into pre-existing circuitry still needs to be achieved. Nevertheless, in vitro neuronal stem cell-derived models hold great promise for clinical application in neurological diseases in the future.

14 January 2020 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
NSNopparat Suthprasertporn
Nopparat Suthprasertporn
NMNopparada Mingchinda
Nopparada Mingchinda
Kohji FukunagaKohji Fukunaga
Kohji Fukunaga
WTWipawan Thangnipon
Wipawan Thangnipon

1 January 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
WTWipawan Thangnipon
Wipawan Thangnipon
NPNicha Puangmalai
Nicha Puangmalai
NSNirut Suwanna
Nirut Suwanna
RSRungtip Soi-Ampornkul
Rungtip Soi-Ampornkul
RPRuchee Phonchai
Ruchee Phonchai
SNSaksit Nobsathian
Saksit Nobsathian